Skip to main content

Table 2 Outcomes of patients after treatment with relugolix

From: Characteristics of submucosal leiomyomas that could cause severe hemorrhage with relugolix: an observational study

 

Total (N = 17)

Severe vaginal bleedinga, n (%)

2 (12)

Hemoglobin (g/dL), median (IQR)b

13.1 (12.1–14.1)

Diameter of leiomyomac (mm), median (IQR)

26.0 (23.0–47.0)

Reduction rate of leiomyomac (%), median (IQR)

25.0 (8.1–29.6)

  1. IQR Interquartile range
  2. aThe two patients developed severe hemorrhage and subsequently received emergent vaginal myomectomy and transfusions
  3. bThere were missing variables in post-treatment hemoglobin (two patients)
  4. cIn cases where patients had multiple leiomyomas, we evaluated the largest submucosal leiomyoma